Cargando…
siRNAs: Potential therapeutic agents against Hepatitis C Virus
Hepatitis C virus is a major cause of chronic liver diseases which can lead to permanent liver damage, hepatocellular carcinoma and death. The presently available treatment with interferon plus ribavirin, has limited benefits due to adverse side effects such as anemia, depression and "flu-like&...
Autores principales: | Ashfaq, Usman A, Yousaf, Muhammad Z, Aslam, Maida, Ejaz, Rahat, Jahan, Shah, Ullah, Obaid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3118364/ https://www.ncbi.nlm.nih.gov/pubmed/21645341 http://dx.doi.org/10.1186/1743-422X-8-276 |
Ejemplares similares
-
Down-regulation of IRES containing 5'UTR of HCV genotype 3a using siRNAs
por: Khaliq, Saba, et al.
Publicado: (2011) -
RNAi therapeutics: Can siRNAs conquer SARS?
por: Chang, Z, et al.
Publicado: (2005) -
Effect of combined siRNA of HCV E2 gene and HCV receptors against HCV
por: Jahan, Shah, et al.
Publicado: (2011) -
In vivo therapeutic potential of Dicer-hunting siRNAs targeting infectious hepatitis C virus.
por: Watanabe, Tsunamasa, et al.
Publicado: (2014) -
Progress in the Therapeutic Applications of siRNAs Against HIV-1
por: Martínez, Miguel Angel
Publicado: (2008)